July 24, 2025 - 18:18
Hi-tech surveillance technologies are a double-edged sword. On one hand, there is a desire for sophisticated devices that can detect suspicious behavior and alert authorities. On the other, there is a pressing need to address privacy concerns and the potential for misuse of such technologies.
The latest advancement in this realm involves a novel system that can track individuals by analyzing how they disrupt Wi-Fi signals. This technology operates on the premise that every person creates a unique disturbance in wireless networks as they move through spaces. By monitoring these disturbances, the system can pinpoint a person's location and movements with remarkable accuracy.
While proponents argue that this technology could enhance security measures in public spaces, critics warn of the implications for personal privacy. The ability to monitor individuals without their consent raises ethical questions about surveillance in modern society. As this technology continues to evolve, a critical dialogue about its applications and limitations is essential to ensure a balance between security and individual rights.
July 25, 2025 - 23:43
Amit Mehra Joins OXON Technologies as Senior Advisor to Boost Climate-Tech InitiativesLONDON, UK – OXON Technologies, a leader in deep-tech innovations aimed at enhancing fuel efficiency and reducing industrial emissions, has announced the appointment of Amit Mehra as Senior...
July 25, 2025 - 13:02
Celebrating Excellence: Colorado's Top CIOs Acknowledged at 2025 ORBIE AwardsDENVER, July 24, 2025 — The 2025 Colorado ORBIE Awards have celebrated the outstanding achievements of leading technology executives who have made significant impacts in their organizations. This...
July 24, 2025 - 02:27
Marvell Technology Positioned for Growth in AI InfrastructureMarvell Technology, Inc. has emerged as a leading player in the AI sector, showcasing significant upside potential. Recently, a prominent financial firm reaffirmed its confidence in Marvell,...
July 23, 2025 - 04:34
FDA Suspends Sarepta's Gene Therapy Designation Amid Safety ConcernsThe FDA has officially revoked the designation for Sarepta’s gene therapy platform technology aimed at treating muscular dystrophy, following a series of patient fatalities linked to its clinical...